Uso de vitamina D para disminuir el riesgo cardiovascular en pacientes con diabetes mellitus tipo II: Una revisión sistemática

Autores/as

DOI:

https://doi.org/10.33448/rsd-v10i7.16862

Palabras clave:

Vitamin D; Doença cardiovascular; Diabetes Mellitus.

Resumen

Introducción: La diabetes mellitus es una enfermedad cada vez más prevalente en el mundo moderno, estando altamente relacionada con factores genéticos y conductuales y causando numerosos problemas de salud pública. Objetivo: analizar el uso de vitamina D para reducir el riesgo cardiovascular en pacientes con diabetes mellitus tipo 2. Métodos: Se realizó una revisión sistemática de la literatura. Para la elaboración del estudio se realizó una búsqueda de datos nacionales e internacionales, seguida de la elección de los criterios de elegibilidad considerando el idioma del artículo (inglés y portugués), textos completos y publicados en los últimos 10 años. En secuencia, a partir de la lectura de los títulos y posterior análisis de los resúmenes, la muestra final estuvo conformada por 13 publicaciones. Resultados: Se detectó un número bajo de publicaciones, sin embargo, se encontró que la vitamina D y sus análogos tienen una eficacia directa sobre los marcadores utilizados para predecir el riesgo cardiovascular de los pacientes, aunque aún existen dudas sobre sus mecanismos de acción. Conclusiones: La intervención con vitamina D tiene buenos resultados en cuanto a reducción de marcadores de riesgo cardiovascular en pacientes diabéticos. Sin embargo, se deben realizar más investigaciones para esclarecer mejor la correlación entre los niveles de vitamina D y la disminución de eventos cardiovasculares, además de mejorar sus mecanismos fisiológicos, estrategias terapéuticas y sus efectos en los más diversos perfiles poblacionales, con el fin de diseñar efectivos y intervenciones concluyentes.

Citas

Annweiler, C., Dursun, E., Féron, F., Gezen-Ak, D., Kalueff, A. V., Littlejohns, T., Llewellyn, D. J.; Millet, P., Scott, T., & Tucker, K. L. (2014) Vitamin D and cognition in older adults’: updated international recommendations. Journal Of Internal Medicine, 277(1), 45-57. http://dx.doi.org/10.1111/joim.12279.

Angellotti, E., D'alessio, D., Dawson-Hughes, B., Chu, Y., Nelson, J., Hu, P., Cohen, R. M., & Pittas, A. G. (2019) Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. Clinical Nutrition, 38(5), 2449-2453. http://dx.doi.org/10.1016/j.clnu.2018.10.003.

Aguiar, C., Duarte, R., Carvalho, D. (2019) Nova abordagem para o tratamento da diabetes: da glicemia à doença cardiovascular. Revista Portuguesa de Cardiologia, 38(1), 53-63. https://doi.org/10.1016/j.repc.2018.03.013

Carrillo-Larco, R. M. & Bernabé-Ortiz, A. (2019) DIABETES MELLITUS TIPO 2 EN PERÚ: UNA REVISIÓN SISTEMÁTICA SOBRE LA PREVALENCIA E INCIDENCIA EN POBLACIÓN GENERAL. Rev Peru Med Exp Salud Publica, 36(1), 26-36. http://dx.doi:10.17843/rpmesp.2019.361.4027.

Ebrahimkhani, S., Ghavamzadeh, & S., Mehdizadeh, A. (2020) The effects of vitamin D and curcuminoids supplementation on anthropometric measurements and blood pressure in type 2 diabetic patients with coexisting hypovitaminosis D: a double-blind, placebo-controlled randomized clinical trial. Clinical Nutrition Espen, 37, 178-186. http://dx.doi.org/10.1016/j.clnesp.2020.02.017.

Forouhi, N. G., Menon, R. K., Sharp, S. J.; Mannan, N., Timms, P. M.; Martineau, A. R., Rickard, A. P., Boucher, B. J., Chowdhury, T. A., & Griffiths, C. J. (2016) Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial. Diabetes, Obesity And Metabolism, 18(4), 392-400. http://dx.doi.org/10.1111/dom.12625.

Galvão, M. C. B.; & Ricarte, I. L. M. (2019) REVISÃO SISTEMÁTICA DA LITERATURA: conceituação, produção e publicação. Logeion: Filosofia da Informação, 6(1), 57-73. http://dx.doi.org/10.21728/logeion.2019v6n1.p57-73.

Heravifard, S.; Neyestani, T. R.; Nikooyeh, B.; Alavi-Majd, H.; Houshiarrad, A.; Kalayi, A.; Shariatzadeh, N.; Zahedirad, M.; Tayebinejad, N.; & Salekzamani, S. (2013) Regular Consumption of Both Vitamin D– and Calcium- and Vitamin D–Fortified Yogurt Drink Is Equally Accompanied by Lowered Blood Lipoprotein (a) and Elevated Apoprotein A1 in Subjects with Type 2 Diabetes: a randomized clinical trial. Journal Of The American College Of Nutrition, 32(1), 26-30. http://dx.doi.org/10.1080/07315724.2013.767659.

Hirschler, V., Maccallini, G., Sanchez, M., Claudio, G., Molinari, C., Figueroa, M., Arnada, C., & Hidalgo, M. (2015) Improvement of Apolipoprotein B in Argentine Indigenous School Children after Vitamin D Supplementation. Cardiovascular & Hematological Agents In Medicinal Chemistry. 13 (2), 137-145. http://dx.doi.org/10.2174/1871525712666140516102319.

Liefaard, M. C., Ligthart, S., Vitezova, A., Hofman, A., Uitterlinden, A. G., Jong, J. C. K., Franco, O. H., Zillikens, M. C., & Dehghan, A. (2015) Vitamin D and C-Reactive Protein: a mendelian randomization study. Plos One, 10(7), 1-12. http://dx.doi.org/10.1371/journal.pone.0131740.

Lu, Y., Hajifathalian, K., Ezzati, M., Woodward, M., Rimm, E. B., & Danaei, G. (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1•8 million participants. The Lancet, 383 (9921), 970-983. http://dx.doi.org/10.1016/s0140-6736(13)61836-x.

Kelishadi, R., Salek, S., Salek, M., Hashemipour, M., & Movahedian, M. (2014) Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. Jornal de Pediatria (Versão em Português), 90(1), 28-34. http://dx.doi.org/10.1016/j.jpedp.2013.06.005.

Muscogiuri, G., Altieri, B., Annweiler, C., Balercia, G., Pal, H. B., Boucher, B. J., Cannell, J. J., Foresta, C., Grübler, M. R., & Kotsa, K. (2016) Vitamin D and chronic diseases: the current state of the art. Archives Of Toxicology, 91(1). 97-107. http://dx.doi.org/10.1007/s00204-016-1804-x.

Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Diretrizes metodológicas: Sistema GRADE – Manual de graduação da qualidade da evidência e força de recomendação para tomada de decisão em saúde: Ministério da Saúde; 2014. http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_sistema_grade.pdf

Mcdonnell, S. L., Baggerly, C., French, C. B., Baggerly, L. L., Garland, C. F., Gorham, E. D., Lappe, J. M., & Heaney, R. P. (2016) Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: pooled analysis of randomized trial and prospective cohort study. Plos One, 11(4), 1-15. http://dx.doi.org/10.1371/journal.pone.0152441.

Nikooyeh, B., Neyestani, T. R., Tayebinejad, N., Alavi-Majd, H., Shariatzadeh, N., Kalayi, A., Zahedirad, M., Heravifard, S., & Salekzamani. (2013) S. Daily intake of vitamin D- or calcium-vitamin D-fortified Persian yogurt drink (doogh) attenuates diabetes-induced oxidative stress: evidence for antioxidative properties of vitamin d. Journal Of Human Nutrition And Dietetics, 27, 276-283, 5. http://dx.doi.org/10.1111/jhn.12142.

Nakashima, A., Yokoyama, K., Yokoo, T., & Urashima, M. (2016) Role of vitamin D in diabetes mellitus and chronic kidney disease. World Journal Of Diabetes, 7(5), 89-100, http://dx.doi.org/10.4239/wjd.v7.i5.89.

Omidian, M., Mahmoudi, M., Javanbakht, M. H., Eshraghian, M. R., Abshirini, M., Daneshzad, E., Hasani, H., Alvandi, E., & Djalali, M. (2019) Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: a randomized, placebo-controlled, double-blind clinical trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(5), 2873-2877. http://dx.doi.org/10.1016/j.dsx.2019.07.047.

Odutayo, A., Wong, Christopher X; Hsiao, Allan J., Hopewell, Sally; A., Douglas, G.; & A Emdin, C. (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ, 6(5), 1-11. http://dx.doi.org/10.1136/bmj.i4482.

PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses. (s.l.): University of Ottawa/Oxford University, 2015. Disponível em: http://www.prisma-statement.org/PRISMAStatement/. Acesso em: 2 abr. 2018.

Ryu, O., Chung, W., Lee, S., Hong, K., Choi, M., & Yoo, H. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. (2014) The Korean Journal Of Internal Medicine, 29(5), 620-629. http://dx.doi.org/10.3904/kjim.2014.29.5.620.

Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., & Parkhomenko, A. (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. The Lancet, 383(9921), 955-962. http://dx.doi.org/10.1016/s0140-6736(13)62343-0.

Riek, A. E., Oh, J., Darwech, I., Worthy, V., Lin, X., Ostlund, R. E., Zhang, R. M., & Bernal-Mizrachi, C. (2018) Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes. The Journal Of Steroid Biochemistry And Molecular Biology, 177, 187-192. http://dx.doi.org/10.1016/j.jsbmb.2017.09.011.

SOCIEDADE BRASILEIRA DE DIABETES (SBD). (2019-2020) Diretrizes da Sociedade Brasileira de Diabetes. São Paulo: AC Farmacêutica, 2019. https://www.diabetes.org.br/profissionais/images/DIRETRIZES-COMPLETA-2019-2020.pdf

Strain, W. D. & Paldánius, P. M. (2018) Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol, 17(1), 57. http://dx.doi.org/10.1186/s12933-018-0703-2

Shab-Bidar, S., Neyestani, T. R., Djazayery, A., Eshraghian, M., Houshiarrad, A., Gharavi, A., Kalayi, A., Shariatzadeh, N., Zahedirad, M., & Khalaji, N. (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. Bmc Medicine, 9(1), 1-10. http://dx.doi.org/10.1186/1741-7015-9-125.

Steele, J. M., Urbina, E. M., Mazur, W. M., Khoury, P. R., Nagueh, S. F., Tretter, J. T., & Alsaied, T. (2020) Left atrial strain and diastolic function abnormalities in obese and type 2 diabetic adolescents and young adults. Cardiovascular Diabetology, 19(1), 1043-1053. http://dx.doi.org/10.1186/s12933-020-01139-9.

Sharma, A., Zhao, X., Hammill, B. G., Hernandez, A. F., Fonarow, G. C., Felker, G. M., Yancy, C. W., Heidenreich, P. A., Ezekowitz, J. A., & Devore, A. (2018) D. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure. Circulation: Heart Failure, 11(6), 37-40. http://dx.doi.org/10.1161/circheartfailure.117.004646.

Verdoia, M., Nardin, M., Rolla, R., Negro, F., Gioscia, R., Afifeh, A. M. S., Viglione, F., Suryapranata, H., Marcolongo, M., & Luca, G. (2020) Association of lower vitamin D levels with inflammation and leucocytes parameters in patients with and without diabetes mellitus undergoing coronary angiography. European Journal Of Clinical Investigation, 51(4), 134-139. http://dx.doi.org/10.1111/eci.13439.

Wacker, M., & Holick, M. Vitamin D. (2013) Effects on Skeletal and Extraskeletal Health and the Need for Supplementation. Nutrients, v. 5, n. 1, p. 111-148, 10 jan. http://dx.doi.org/10.3390/nu5010111.

Zittermann, A. (2018). Vitamin D Status, Supplementation and Cardiovascular Disease. Anticancer Research, 38(2), 1179-1186. http://dx.doi.org/10.21873/anticanres.12338.

Zaheer, S., Taquechel, K., Brown, J. M., Adler, G. K., Williams, J. S., & Vaidya, A. (2018) A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes. Journal Of The Renin-Angiotensin-Aldosterone System, v. 19(1), 1-8. http://dx.doi.org/10.1177/1470320317754178.

Zittermann, A., Ernst, J. B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., Knabbe, C., Börgermann, J.; Berthold, H. K., & Pilz, S. (2018) Daily Supplementation with 4000 IU Vitamin D3 for Three Years Does Not Modify Cardiovascular Risk Markers in Patients with Advanced Heart Failure: the effect of vitamin d on mortality in heart failure trial. Annals Of Nutrition And Metabolism, 74(1), 62-68. http://dx.doi.org/10.1159/000495662.

Publicado

30/06/2021

Cómo citar

DINIZ, R. B.; FARIAS, T. B. C. de .; SOUSA , M. N. A. de . Uso de vitamina D para disminuir el riesgo cardiovascular en pacientes con diabetes mellitus tipo II: Una revisión sistemática. Research, Society and Development, [S. l.], v. 10, n. 7, p. e49810716862, 2021. DOI: 10.33448/rsd-v10i7.16862. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/16862. Acesso em: 26 nov. 2024.

Número

Sección

Ciencias de la salud